Zhang L, Shen H, Gong Y, Pang X, Yi M, Guo L, et al. Development of a dual-functional conjugate of antigenic peptide and Fc-III mimetics (DCAF) for targeted antibody blocking. Chem Sci. 2019;10:3271-3280 pubmed publisher

Luo J, Lindstrom J. Antigen-specific immunotherapeutic vaccine for experimental autoimmune myasthenia gravis. J Immunol. 2014;193:5044-55 pubmed publisher

Park J, Mott M, Williams T, Ikeda H, Wen H, Linhoff M, et al. A single mutation in the acetylcholine receptor ?-subunit causes distinct effects in two types of neuromuscular synapses. J Neurosci. 2014;34:10211-8 pubmed publisher

Chamberlain Banoub J, Neal J, Mizuno M, Harris C, Morgan B. Complement membrane attack is required for endplate damage and clinical disease in passive experimental myasthenia gravis in Lewis rats. Clin Exp Immunol. 2006;146:278-86 pubmed

Losen M, Stassen M, Martinez Martinez P, Machiels B, Duimel H, Frederik P, et al. Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis. Brain. 2005;128:2327-37 pubmed

Poea Guyon S, Christadoss P, Le Panse R, Guyon T, De Baets M, Wakkach A, et al. Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis. J Immunol. 2005;174:5941-9 pubmed